MOG | Myelin oligodendrocyte glycoprotein | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
MS4A1 | Membrane-spanning 4-domains, subfamily A, member 1 | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
MT-CO2 | Mitochondrially encoded cytochrome c oxidase II | Disease related genes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
MTCH1 | Mitochondrial carrier 1 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
MTX1 | Metaxin 1 | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
NAA25 | N(alpha)-acetyltransferase 25, NatB auxiliary subunit | Predicted membrane proteins
| | | | | Expressed in all |
OCIAD1 | OCIA domain containing 1 | Predicted membrane proteins
| | | | | Expressed in all |
OMA1 | OMA1 zinc metallopeptidase | Cancer-related genes Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
P2RX4 | Purinergic receptor P2X, ligand-gated ion channel, 4 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
P2RX6 | Purinergic receptor P2X, ligand-gated ion channel, 6 | Predicted membrane proteins
| | | | | Tissue enhanced |
PDPN | Podoplanin | Predicted membrane proteins
| | | | | Tissue enhanced |
PEX13 | Peroxisomal biogenesis factor 13 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
PIGH | Phosphatidylinositol glycan anchor biosynthesis, class H | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
PIGN | Phosphatidylinositol glycan anchor biosynthesis, class N | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
PLA2G15 | Phospholipase A2, group XV | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
PLLP | Plasmolipin | Predicted membrane proteins
| | | | | Mixed |
PLP1 | Proteolipid protein 1 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
POLR1E | Polymerase (RNA) I polypeptide E, 53kDa | Predicted membrane proteins RNA polymerase related proteins
| | | | | Expressed in all |
POMT2 | Protein-O-mannosyltransferase 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
PPAP2A | Phosphatidic acid phosphatase type 2A | Enzymes Predicted membrane proteins
| | | | | Mixed |
PREB | Prolactin regulatory element binding | Predicted membrane proteins
| | | | | Expressed in all |
PSEN1 | Presenilin 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
PTPRO | Protein tyrosine phosphatase, receptor type, O | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
RABAC1 | Rab acceptor 1 (prenylated) | Predicted membrane proteins
| | | | | Expressed in all |
RALGAPA1 | Ral GTPase activating protein, alpha subunit 1 (catalytic) | Predicted membrane proteins
| | | | | Expressed in all |
RER1 | Retention in endoplasmic reticulum sorting receptor 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
RNF186 | Ring finger protein 186 | Predicted membrane proteins
| | | | | Tissue enhanced |
RNF19A | Ring finger protein 19A, RBR E3 ubiquitin protein ligase | Predicted membrane proteins
| | | | | Expressed in all |
RPN2 | Ribophorin II | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
RTN1 | Reticulon 1 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
RTN2 | Reticulon 2 | Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |
RTN3 | Reticulon 3 | Predicted membrane proteins
| | | | | Expressed in all |
RTN4 | Reticulon 4 | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
SCAMP2 | Secretory carrier membrane protein 2 | Predicted membrane proteins
| | | | | Expressed in all |
SCAMP5 | Secretory carrier membrane protein 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
SEC63 | SEC63 homolog (S. cerevisiae) | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SFXN4 | Sideroflexin 4 | Disease related genes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SIGMAR1 | Sigma non-opioid intracellular receptor 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
SLC17A7 | Solute carrier family 17 (vesicular glutamate transporter), member 7 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC1A3 | Solute carrier family 1 (glial high affinity glutamate transporter), member 3 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC20A2 | Solute carrier family 20 (phosphate transporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC22A16 | Solute carrier family 22 (organic cation/carnitine transporter), member 16 | Predicted membrane proteins
| | | | | Group enriched |
SLC23A1 | Solute carrier family 23 (ascorbic acid transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC26A3 | Solute carrier family 26 (anion exchanger), member 3 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC26A6 | Solute carrier family 26 (anion exchanger), member 6 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC27A2 | Solute carrier family 27 (fatty acid transporter), member 2 | Enzymes Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC27A4 | Solute carrier family 27 (fatty acid transporter), member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC27A6 | Solute carrier family 27 (fatty acid transporter), member 6 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC28A1 | Solute carrier family 28 (concentrative nucleoside transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC2A2 | Solute carrier family 2 (facilitated glucose transporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |